(NYSE: NVST) Envista Holdings's forecast annual revenue growth rate of 5.16% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 11.28%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 56.85%.
Envista Holdings's revenue in 2026 is $2,621,800,000.On average, 16 Wall Street analysts forecast NVST's revenue for 2026 to be $459,571,321,235, with the lowest NVST revenue forecast at $435,565,091,217, and the highest NVST revenue forecast at $482,590,993,855. On average, 14 Wall Street analysts forecast NVST's revenue for 2027 to be $475,849,518,302, with the lowest NVST revenue forecast at $452,336,566,983, and the highest NVST revenue forecast at $502,157,715,582.
In 2028, NVST is forecast to generate $495,909,518,728 in revenue, with the lowest revenue forecast at $470,094,600,147 and the highest revenue forecast at $517,449,355,251.